Last update 21 Nov 2024

WO2024018241

Patent Mining

Overview

Basic Info

Drug Type
Nanobody
Synonyms-
Target
IL-12Rβ2
Mechanism-
Therapeutic Areas
Immune System DiseasesNervous System DiseasesEye Diseases+ [1]
Active Indication
Eye DiseasesImmune System DiseasesMusculoskeletal Diseases+ [1]
Inactive Indication-
Originator Organization
Dualyx NVDualyx NVVlaams Instituut voor Biotechnologie - Flanders InstituteVlaams Instituut voor Biotechnologie - Flanders InstituteGhent UniversityGhent University
Active Organization
Ghent UniversityGhent UniversityDualyx NVDualyx NVVlaams Instituut voor Biotechnologie - Flanders InstituteVlaams Instituut voor Biotechnologie - Flanders Institute
Inactive Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WO2024018241
Login to view more data
100 Translational Medicine associated with WO2024018241
Login to view more data
100 Patents (Medical) associated with WO2024018241
Login to view more data
100 Deals associated with WO2024018241
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Eye DiseasesDiscovery-
Vlaams Instituut voor Biotechnologie - Flanders InstituteVlaams Instituut voor Biotechnologie - Flanders Institute
25 Jan 2024
Eye DiseasesDiscovery-
Dualyx NVDualyx NV
25 Jan 2024
Eye DiseasesDiscovery-
Ghent UniversityGhent University
25 Jan 2024
Immune System DiseasesDiscovery-
Ghent UniversityGhent University
25 Jan 2024
Musculoskeletal DiseasesDiscovery-
Dualyx NVDualyx NV
25 Jan 2024
Musculoskeletal DiseasesDiscovery-
Ghent UniversityGhent University
25 Jan 2024
Musculoskeletal DiseasesDiscovery-
Vlaams Instituut voor Biotechnologie - Flanders InstituteVlaams Instituut voor Biotechnologie - Flanders Institute
25 Jan 2024
Nervous System DiseasesDiscovery-
Vlaams Instituut voor Biotechnologie - Flanders InstituteVlaams Instituut voor Biotechnologie - Flanders Institute
25 Jan 2024
Nervous System DiseasesDiscovery-
Ghent UniversityGhent University
25 Jan 2024
Nervous System DiseasesDiscovery-
Dualyx NVDualyx NV
25 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free